Apremilast Survival and Reasons for Discontinuation in Psoriasis: Five-Year Experience From a Greek Tertiary Care Centre.

Sotiriou, Elena; Tsentemeidou, Aikaterini; Sideris, Nikolaos; Lallas, Aimilios; Kougkas, Nikolaos; Ioannides, Dimitrios; Vakirlis, Efstratios

Sotiriou, Elena; Tsentemeidou, Aikaterini; Sideris, Nikolaos; Lallas, Aimilios; Kougkas, Nikolaos; Ioannides, Dimitrios; Vakirlis, Efstratios.

Afiliação

Sotiriou E; First Department of Dermatology and Venereology, School of Medicine, Aristotle University, Thessaloniki, Greece.
Tsentemeidou A; First Department of Dermatology and Venereology, School of Medicine, Aristotle University, Thessaloniki, Greece.
Sideris N; First Department of Dermatology and Venereology, School of Medicine, Aristotle University, Thessaloniki, Greece.
Lallas A; First Department of Dermatology and Venereology, School of Medicine, Aristotle University, Thessaloniki, Greece.
Kougkas N; Fourth Department of Internal Medicine, Aristotle University of Thessaloniki, Greece.
Ioannides D; First Department of Dermatology and Venereology, School of Medicine, Aristotle University, Thessaloniki, Greece.
Vakirlis E; First Department of Dermatology and Venereology, School of Medicine, Aristotle University, Thessaloniki, Greece.

Dermatol Pract Concept ; 12(2): e2022076, 2022 May.

Article em En | MEDLINE | ID: mdl-35646455

Palavras-chave

Greece; apremilast; discontinuation; psoriasis; survival

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Revista: Dermatol Pract Concept Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Grécia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google